Anebulo Pharmaceuticals Ownership | Who Owns Anebulo Pharmaceuticals?


OverviewForecastFinancialsChart

Anebulo Pharmaceuticals Ownership Summary


Anebulo Pharmaceuticals is owned by 28.32% institutional investors, 64.22% insiders, and 7.46% retail investors. 22nw, lp is the largest institutional shareholder, holding 20.69% of ANEB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.47% of its assets in Anebulo Pharmaceuticals shares.

ANEB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnebulo Pharmaceuticals28.32%64.22%7.46%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
22nw, lp5.37M20.69%$14.65M
Lvw advisors642.04K2.48%$1.75M
Nantahala capital management511.07K1.97%$1.40M
Morgan stanley399.22K1.54%$1.09M
Ikarian capital157.86K0.61%$430.96K
Vanguard group153.87K0.59%$420.07K
Geode capital management51.31K0.20%$140.13K
Boothbay fund management18.98K0.07%$51.81K
Blackrock3.76K0.01%$10.27K
Tower research capital llc (trc)3.30K0.01%$9.01K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
22nw, lp5.37M12.50%$14.65M
Lvw advisors642.04K0.26%$1.75M
Nantahala capital management511.07K0.08%$1.40M
Ikarian capital157.86K0.08%$430.96K
Boothbay fund management18.98K0.00%$51.81K
Tower research capital llc (trc)3.30K0.00%$9.01K
Morgan stanley399.22K0.00%$1.09M
Bank of america corp /de/65.00-$177.00
Susquehanna group, llp---
Blackrock3.76K-$10.27K

Top Buyers

HolderShares% AssetsChange
Geode capital management51.31K-28.53K
Vanguard group153.87K-401.00
Bank of america corp /de/65.00-65.00
Jpmorgan chase10.00-1.00
22nw, lp5.37M12.50%-

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp---25.25K
Tower research capital llc (trc)3.30K0.00%-1.84K
Blackrock3.76K--288.00
Ubs group---144.00
Wells fargo & company/mn---62.00

Sold Out

HolderChange
Wells fargo & company/mn-62.00
Ubs group-144.00
Susquehanna group, llp-25.25K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024138.33%7,343,7340.49%283.57%525.00%350.00%
Jun 30, 202412-14.29%7,307,7780.02%283.51%4-33.33%2-33.33%
Mar 31, 2024147.69%7,306,3650.38%283.56%6-14.29%3-
Dec 31, 20231318.18%7,278,9933.24%283.57%740.00%350.00%
Sep 30, 202311-7,050,4910.26%283.74%525.00%2-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv121.00K0.47%-
Fidelity Extended Market Index54.63K0.21%10.23K
Vanguard Institutional Extnd Mkt Idx Tr33.04K0.13%-
Fidelity Total Market Index14.73K0.06%14.73K
Fidelity Series Total Market Index11.84K0.05%11.00K
Northern Trust Extended Eq Market Idx6.62K0.03%-
NT Ext Equity Mkt Idx Fd - L6.62K0.03%-
Fidelity Nasdaq Composite Index4.11K0.02%-
iShares Micro-Cap ETF3.52K0.01%-
Spartan Extended Market Index Pool E1.33K0.01%179.00

Recent Insider Transactions


DateNameRoleActivityValue
Dec 17, 2021English Aron R. Buy$2.63K
Dec 14, 2021English Aron R. Buy$2.43K
Dec 03, 2021English Aron R. Buy$26.68K
Dec 02, 2021English Aron R. Buy$73.33K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3--

ANEB Ownership FAQ


Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals shareholders are primarily institutional investors at 28.32%, followed by 64.22% insiders and 7.46% retail investors. The average institutional ownership in Anebulo Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Anebulo Pharmaceuticals falls below.

Who owns the most shares of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals’s largest shareholders are 22nw, lp (5.37M shares, 20.69%), Lvw advisors (642.04K shares, 2.48%), and Nantahala capital management (511.07K shares, 1.97%). Together, they hold 25.14% of Anebulo Pharmaceuticals’s total shares outstanding.

Does Blackrock own Anebulo Pharmaceuticals?

Yes, BlackRock owns 0.01% of Anebulo Pharmaceuticals, totaling 3.76K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 10.27K$. In the last quarter, BlackRock decreased its holdings by -288 shares, a -7.11% change.

Who is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

22nw, lp is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.50% of its assets in 5.37M Anebulo Pharmaceuticals shares, valued at 14.65M$.

Who is the top mutual fund holder of Anebulo Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Anebulo Pharmaceuticals shares, with 0.47% of its total shares outstanding invested in 121K Anebulo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools